THE BUSINESS OF BIOTECH
Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie
On this episode of the Business of Biotech, host Ben Comer speaks with Brian Lortie, President and CEO of Uniquity Bio, about his "no jerk" policy and how his experience building teams at GSK, Endo Pharmaceuticals, and Onspira Therapeutics informs his leade...
ABOUT THE BUSINESS OF BIOTECH
Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.
FEATURED GUESTS
Brian Lortie
Allan Shaw
Sara Bonstein
David Sans
Nima Farzan
Kasper Roet
Rick Modi
Brad Sitko
Owen Hughes
Thomas Chalberg
MEET YOUR HOST
Ben Comer is chief editor of Life Science Leader magazine. He has covered the biopharmaceutical, medtech and medical device industries for 15 years as a reporter and editor, and worked as a senior manager in PwC’s Health Research Institute.
Interested in joining us on air? Contact us
THE BUSINESS OF BIOTECH PODCAST
FINANCE & CAPITAL MARKETS
DISCOVERY/R&D
